Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.
Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Gómez C, Perea S, Ruiz A, Hitt R, Cortés-Funes H. Hidalgo M, et al. Among authors: gomez c. Antimicrob Agents Chemother. 1997 May;41(5):1175-7. doi: 10.1128/AAC.41.5.1175. Antimicrob Agents Chemother. 1997. PMID: 9145895 Free PMC article. Clinical Trial.
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.
Perea S, Hidalgo M, Arcediano A, Ramos MJ, Gomez C, Hornedo J, Lumbreras C, Folgueira D, Cortes-Funes H, Rodriguez-Noriega A. Perea S, et al. Among authors: gomez c. J Antimicrob Chemother. 1999 Jul;44(1):117-20. doi: 10.1093/jac/44.1.117. J Antimicrob Chemother. 1999. PMID: 10459819
Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.
García-Carbonero R, Mayordomo JI, Tornamira MV, López-Brea M, Rueda A, Guillem V, Arcediano A, Yubero A, Ribera F, Gómez C, Trés A, Pérez-Gracia JL, Lumbreras C, Hornedo J, Cortés-Funes H, Paz-Ares L. García-Carbonero R, et al. Among authors: gomez c. J Natl Cancer Inst. 2001 Jan 3;93(1):31-8. doi: 10.1093/jnci/93.1.31. J Natl Cancer Inst. 2001. PMID: 11136839 Free article. Clinical Trial.
p53 expression in locally advanced pharyngeal squamous cell carcinoma.
Lassaletta L, Brandáriz JA, Benito A, de la Cruz J, Gómez C, Ballestín C, Hitt R, Colomer R, Alvarez-Vicent JJ. Lassaletta L, et al. Among authors: gomez c. Arch Otolaryngol Head Neck Surg. 1999 Dec;125(12):1356-9. doi: 10.1001/archotol.125.12.1356. Arch Otolaryngol Head Neck Surg. 1999. PMID: 10604414
[Necrotic surgical wound].
González A, del Palacio A, Lumbreras C, Rodríguez-Peralto JL, Carabias E, Gómez C, Cuétara MS. González A, et al. Among authors: gomez c. Enferm Infecc Microbiol Clin. 1995 Aug-Sep;13(7):435-6. Enferm Infecc Microbiol Clin. 1995. PMID: 8519822 Spanish. No abstract available.
Consensus on the treatment of pancreatic cancer in Spain.
Hidalgo M, Abad A, Aranda E, Díez L, Feliu J, Gómez C, Irigoyen A, López R, Rivera F, Rubio C, Sastre J, Tabernero J, Díaz-Rubio E. Hidalgo M, et al. Among authors: gomez c. Clin Transl Oncol. 2009 May;11(5):290-301. doi: 10.1007/s12094-009-0357-3. Clin Transl Oncol. 2009. PMID: 19451062 Review.
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.
Cortes-Funes H, Gomez C, Rosell R, Valero P, Garcia-Giron C, Velasco A, Izquierdo A, Diz P, Camps C, Castellanos D, Alberola V, Cardenal F, Gonzalez-Larriba JL, Vieitez JM, Maeztu I, Sanchez JJ, Queralt C, Mayo C, Mendez P, Moran T, Taron M. Cortes-Funes H, et al. Among authors: gomez c. Ann Oncol. 2005 Jul;16(7):1081-6. doi: 10.1093/annonc/mdi221. Epub 2005 Apr 25. Ann Oncol. 2005. PMID: 15851406 Free article.
[Detection of p53 protein in advanced head and neck cancer].
Lassaletta L, Brandáriz JA, Benito A, Gómez C, Ballestín C, Hitt R, De La Cruz J, Alvarez-Vicent JJ. Lassaletta L, et al. Among authors: gomez c. Acta Otorrinolaringol Esp. 1999 Nov-Dec;50(8):613-8. Acta Otorrinolaringol Esp. 1999. PMID: 10619896 Spanish.
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study.
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Maestro-de la Calle G, Sánchez-Fernández M, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, San Juan R, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM. de la Calle C, et al. Among authors: gomez c. Int J Infect Dis. 2021 Apr;105:319-325. doi: 10.1016/j.ijid.2021.02.041. Epub 2021 Feb 13. Int J Infect Dis. 2021. PMID: 33592340 Free PMC article.
2,683 results